Home · Diabetes and Endocrinology · Condition
Diabetes and Endocrinology · Refer Your Patient
Copied from the official Gold Coast Health condition page (27 Aug 2026). Hospital triage assigns the official category. Live source: Refer Your Patient — Gender Incongruence.
Cat 1 · 30 days
appointment within 30 calendar days. - Severe psychological distress directly related to gender incongruence/dysphoria resulting in immediate significant risk (e.g. suicidal ideation, genital mutilation) - Patients expressing regret in relation to medical or surgical gender affirming treatments - Patients already on gender-affirming hormone therapy (GAHT) with absolute (urgent) contraindications (e.g. venous thromboembolism, oestrogen sensitive malignancy, psychosis)
Cat 2 · 90 days
appointment within 90 calendar days. - Medical assessment and initiation of GAHT for those aged >17 years - People seeking other gender-affirming therapies due to gender incongruence/dysphoria (e.g. psychology, psychiatry, speech pathology, social work) - People seeking mental health assessment and formal documentation to undergo gender-affirming surgery (where relevant) - Patients already on GAHT with relative contraindications (e.g. polycythaemia with no symptoms of acute thrombosis, non-acute/controlled cardiovascular conditions, other mood disturbance with no active suicidal ideation or severe mental health crisis) (Referred to Endocrinology)
Cat 3 · 365 days
appointment within 365 calendar days. - Patients already on GAHT requiring routine follow-up (e.g. dose adjustments) for those aged >17 years (Referred to Endocrinology)
Referral will be returned without this. If a mandatory test cannot be obtained, say so in the referral.
- Brief gender-related history: preferred name, sex assigned at birth, gender identity, pronouns used - Relevant social history, including any safety concerns for the patient (e.g. whether it is safe for the Gender Service to contact the patient using the contact details provided in the referral) - Mental Health diagnoses (patients must have managed/supported mental health before being prescribed GAHT. Please manage any mental health concerns, including referrals to mental health care providers while the patient awaits their appointment). Please provide information on the following: - Diagnoses: mood disorder (anxiety, depression), disordered eating or eating disorder, psychotic illness, chronic severe mental health issue and whether the patient is under the care of a mental health specialist or team - Mental health risks - If no known mental health issues/if stable/well-supported - Any neurodevelopment diagnoses/concerns (where relevant) - Physical Health diagnoses: - All current medical conditions (e.g. cardiovascular disease, cerebrovascular disease, haematological disease (including venous thromboembolism), diabetes, obesity, osteoporosis, hormone-dependent cancer (including breast cancer)) - Please document if there are no pre-existing medical conditions. - Current medications including dose(s) - Allergies - Individuals newly seeking gender-affirming hormone therapy should have the following essential blood tests completed: - Full Blood Count (FBC); Electrolyte and Liver Function Tests (E/LEFTs); glucose/HbA1C, fasting lipids, oestradiol, testosterone, Luteinsing Hormone (LH), Follicle-Stimulating Hormone (FSH), vitamin D. (It is critical that these tests have been conducted within the past six months for persons initiating GAHT). - The results of blood tests must be included in the referral, otherwise the referral will be declined. Please note: it is the duty of care of the GP ordering blood tests to follow up any abnormal results.
The following conditions are out of scope for this service: - Pre-diabetes - Stable, well-controlled type 2 diabetes - Newly diagnosed type 2 diabetes and not acutely unwell - Referrals where the primary problem requiring attention is not directly related to the diabetes and should be directed to another speciality service e.g. chest pain for investigation should go to cardiology - Dietary advice for weight reduction, high cholesterol, hypertension or CVD in patients with diabetes - Newly diagnosed primary hypothyroidism, including subclinical hypothyroidism – Note: in women of child bearing age who are pregnant or wishing to become pregnant or not using contraception, thyroxine should be commenced and titrated, aiming for a TSH less than 2.5 - Positive thyroid antibodies with normal thyroid function - Osteopaenia - Routine uncomplicated osteoporosis
Parent service: Diabetes and Endocrinology
Sign in for localised assessment and management. HealthPathways does not send the referral. Register: gchealthpathways@health.qld.gov.au